Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol, Version 6, 08 Jul 2020, MHRA
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
G. Organisation Responsibilities
Appendix I - Expectations for Specific Serious Breach Topics
Appendix II Examples of Serious Breaches Notified to MHRA (this is not an exhaustive list)
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
Upcoming Clinical Trials
-
NCT05880784RecruitingClinical Audit Package of Essential Non-Communicable Diseases (PEN) Peer Coaching Mixed Method Implementation Study
-
NCT05880628Recruiting
-
NCT05880641Not yet recruitingPeripheral Arterial Disease Aortic Diseases Aorto-Iliac Atherosclerosis
-
NCT05880758RecruitingObesity Cardiometabolic Syndrome
-
NCT05880602Not yet recruitingUrinary Tract Infection
-
NCT05880680Not yet recruitingAneurysm Aneurysm, Ruptured
-
NCT05880576Not yet recruitingCoarctation of the Aorta Aortic Arch Obstruction
-
NCT05880810Not yet recruiting
-
NCT05880589Recruiting
-
NCT05880706Not yet recruitingNon-small Cell Lung Cancer
-
NCT05880667Not yet recruitingMalignant Neoplasm of Stomach Neoplasm - Soft Tissue Pelvis Malignant Secondary
Clinical Research Jobs
-
Clinical Trial Associate - Client-dedicated - Belgium
-
Principal Reg Affairs Spec
-
Technicien Chromatographie - H/F - CDI
-
Animal Care Technician II
-
Director, Global Capital Planning & Contractor Safety
-
Apheresis Registered Nurse - Part Time
-
Animal care Assistant
-
Administratief Project Ondersteuner
-
Technicien animalier cycle VSDL - F/H - CDI
-
Assistant(e) soins aux animaux
-
Assistant Manager Biomanufacturing
-
Technicien Chromatographie Macromolécules - H/F - CDI